[Management of acute asthma in infants and children: recommendations from the French Pediatric Society of Pneumology and Allergy] (Q80237435)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17468701%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

review article

1 reference

title

[Management of acute asthma in infants and children: recommendations from the French Pediatric Society of Pneumology and Allergy] (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17468701%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

C Marguet

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17468701%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

Groupe de Recherche Sur Les Avancées En PneumoPédiatrie

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17468701%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

publication date

1 April 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17468701%20AND%20SRC:MED&resulttype=core&format=json

Revue des Maladies Respiratoires

30 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17468701%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17468701%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

issue

4 Pt 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17468701%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

page(s)

427-439

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17468701%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991567-3

7 January 2021

Differences between asthma exacerbations and poor asthma control

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991567-3

7 January 2021

Food allergy as a risk factor for life-threatening asthma in childhood: a case-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991567-3

7 January 2021

Perception of intrinsic and extrinsic respiratory loads in children with life-threatening asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991567-3

7 January 2021

Poor perception of airway obstruction in children with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991567-3

7 January 2021

Study of modifiable risk factors for asthma exacerbations: virus infection and allergen exposure increase the risk of asthma hospital admissions in children.

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991567-3

7 January 2021

Exposure to an aeroallergen as a possible precipitating factor in respiratory arrest in young patients with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991567-3

7 January 2021

A prospective multicenter study of patient factors associated with hospital admission from the emergency department among children with acute asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991567-3

7 January 2021

Inadequate follow-up controller medications among patients with asthma who visit the emergency department

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991567-3

7 January 2021

Initial oxygen saturation as a predictor of admission in children presenting to the emergency department with acute asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991567-3

7 January 2021

Predictors of hospitalization in children with acute asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991567-3

7 January 2021

Oxygen saturation as a predictor of prolonged, frequent bronchodilator therapy in children with acute asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991567-3

7 January 2021

Risk factors for an intensive care unit admission in children with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991567-3

7 January 2021

Randomised trial of intravenous salbutamol in early management of acute severe asthma in children

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991567-3

7 January 2021

Randomised controlled trial of aminophylline for severe acute asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991567-3

7 January 2021

Intravenous salbutamol bolus compared with an aminophylline infusion in children with severe asthma: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991567-3

7 January 2021

beta-agonists through metered-dose inhaler with valved holding chamber versus nebulizer for acute exacerbation of wheezing or asthma in children under 5 years of age: a systematic review with meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991567-3

7 January 2021

Response to frequent low doses of nebulized salbutamol in acute asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991567-3

7 January 2021

Comparison of single 7.5-mg dose treatment vs sequential multidose 2.5-mg treatments with nebulized albuterol in the treatment of acute asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991567-3

7 January 2021

Short acting beta agonists for recurrent wheeze in children under 2 years of age.

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991567-3

7 January 2021

Inhalation therapy in asthma: nebulizer or pressurized metered-dose inhaler with holding chamber? In vivo comparison of lung deposition in children

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991567-3

7 January 2021

Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991567-3

7 January 2021

Metered-dose inhaler with spacer vs nebulization for severe and potentially severe acute asthma treatment in the pediatric emergency department

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991567-3

7 January 2021

Comparative efficacy of terbutaline sulphate delivered by Turbuhaler dry powder inhaler or pressurised metered dose inhaler with Nebuhaler spacer in children during an acute asthmatic episode

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991567-3

7 January 2021

A prospective, randomized study of continuous versus intermittent nebulized albuterol for severe status asthmaticus in children

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991567-3

7 January 2021

Continuous nebulised salbutamol and oral once a day prednisolone in status asthmaticus

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991567-3

7 January 2021

Continuous subcutaneous infusion of beta 2-agonists in infantile asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991567-3

7 January 2021

Intravenous salbutamol in the treatment of status asthmaticus in children

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991567-3

7 January 2021

The effectiveness of IV beta-agonists in treating patients with acute asthma in the emergency department: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991567-3

7 January 2021

Efficacy of albuterol administered by nebulizer versus spacer device in children with acute asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991567-3

7 January 2021

Metered dose inhaler and nebuliser in acute asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991567-3

7 January 2021

Comparison between nebulized adrenaline and beta2 agonists for the treatment of acute asthma. A meta-analysis of randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991567-3

7 January 2021

Combined inhaled anticholinergic agents and beta-2-agonists for initial treatment of acute asthma in children

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991567-3

7 January 2021

Effect of nebulized ipratropium on the hospitalization rates of children with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991567-3

7 January 2021

Ipratropium bromide added to asthma treatment in the pediatric emergency department

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991567-3

7 January 2021

Benefits of ipratropium bromide in the management of asthmatic crises in the emergency department

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991567-3

7 January 2021

Efficacy of IV theophylline in children with severe status asthmaticus

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991567-3

7 January 2021

Doses of systemic corticosteroids in hospitalised children with acute asthma: A systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991567-3

7 January 2021

Early emergency department treatment of acute asthma with systemic corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991567-3

7 January 2021

Corticosteroids for hospitalised children with acute asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991567-3

7 January 2021

Parent-initiated oral corticosteroid therapy for intermittent wheezing illnesses in children

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991567-3

7 January 2021

Safety profile of frequent short courses of oral glucocorticoids in acute pediatric asthma: impact on bone metabolism, bone density, and adrenal function

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991567-3

7 January 2021

A comparison of inhaled fluticasone and oral prednisone for children with severe acute asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991567-3

7 January 2021

A randomized controlled trial of inhaled flunisolide in the management of acute asthma in children

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991567-3

7 January 2021

High-dose inhaled fluticasone does not replace oral prednisolone in children with mild to moderate acute asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991567-3

7 January 2021

Does magnesium sulphate have a role in the management of paediatric status asthmaticus?

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991567-3

7 January 2021

Comparison of nebulized magnesium sulfate plus albuterol to nebulized albuterol plus saline in children with acute exacerbations of mild to moderate asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991567-3

7 January 2021

Inhaled magnesium sulfate in the treatment of acute asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991567-3

7 January 2021

Inhaled helium-oxygen revisited: effect of inhaled helium-oxygen during the treatment of status asthmaticus in children.

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991567-3

7 January 2021

Heliox for non-intubated acute asthma patients

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991567-3

7 January 2021

Evaluation of heliox in children hospitalized with acute severe asthma. A randomized crossover trial

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991567-3

7 January 2021

Heliox vs air-oxygen mixtures for the treatment of patients with acute asthma: a systematic overview

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991567-3

7 January 2021

Role of viruses and atypical bacteria in exacerbations of asthma in hospitalized children: a prospective study in the Nord-Pas de Calais region (France).

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991567-3

7 January 2021

The association of Chlamydia pneumoniae infection and reactive airway disease in children

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991567-3

7 January 2021

The effect of telithromycin in acute exacerbations of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991567-3

7 January 2021

Effects of chest physical therapy on lung function in children recovering from acute severe asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991567-3

7 January 2021

Factors associated with short-term clinical outcomes after acute treatment of asthma in a pediatric emergency department

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991567-3

7 January 2021

Inhaled steroids in acute asthma following emergency department discharge

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991567-3

7 January 2021

Written action plans for asthma: an evidence-based review of the key components

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991567-3

7 January 2021

Written individualised management plans for asthma in children and adults

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991567-3

7 January 2021

Written action plans for asthma in children

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991567-3

7 January 2021

Effects of educational interventions for self management of asthma in children and adolescents: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991567-3

7 January 2021

Usefulness of monitoring lung function in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991567-3

7 January 2021

Accuracy of mini peak flow meters in indicating changes in lung function in children with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991567-3

7 January 2021

Doubling the dose of budesonide versus maintenance treatment in asthma exacerbations.

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991567-3

7 January 2021

Doubling the dose of inhaled corticosteroid to prevent asthma exacerbations: randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991567-3

7 January 2021

Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991567-3

7 January 2021

Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991567-3

7 January 2021

Adjustable maintenance dosing with budesonide/formoterol compared with fixed-dose salmeterol/fluticasone in moderate to severe asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991567-3

7 January 2021

The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persiste

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991567-3

7 January 2021

10.1016/S0761-8425(07)91567-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17468701%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference